Clinical trial
Odiparcil For The Prevention Of Venous Thromboembolism
NCT00244725 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00244725 |
|---|---|
| Title | Odiparcil For The Prevention Of Venous Thromboembolism |
| Official title | A Dose Ranging Trial for the Evaluation of the Safety, Tolerability and Efficacy of Odiparcil in the Prevention of Venous Thromboembolism Following Total Knee Replacement Surgery |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Deep Vein Thrombosis, Fibrillation, Atrial, Venous Thromboembolism, Pulmonary Embolism |
| Intervention type | Drug |
| Interventions | Odiparcil, Warfarin, Coumadin |
| Enrollment | 961 |
| Start date | Sep 1, 2005 |
| Primary completion | Sep 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Oct 27, 2005 |
| Last update posted | May 2, 2017 |
| Countries | Australia, Brazil, Canada, India, Israel, Latvia, Lithuania, Poland, Russia, South Africa, Ukraine, United Kingdom and 1 more |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: